Abstract
We report a rare case of 62-year-old South Asian women who visited the Molecular Pathology and Genomics Department for hereditary germline cancer genetic testing after being diagnosed with oesophageal cancer, reported as invasive keratinizing squamous cell carcinoma metastasized to the lymph nodes. Her personal history revealed that she was diagnosed with triple-negative breast cancer five years before oesophageal cancer. Germline cancer testing showed pathogenic variants in BRCA1 gene c.68_69delAG, which proved it a hereditary breast and ovarian cancer syndrome. She was started on PARP inhibitors but developed some secondary respiratory failure and succumbed to death. Less than 10 cases have been reported in the literature of the association of germline BRCA1 and Squamous cell Carcinoma – the esophagus. The article focuses on the probable pathogenesis of BRCA1 mutation with non-classic malignancies and the response of Poly adenosine diphosphate ribose polymerase inhibitors (PARP) inhibitors in such a scenario. We report an unusual manifestation of the BRCA1 gene with second primary oesophageal squamous cell cancer occurring five years later to triple-negative breast cancer.
Publisher
Heighten Science Publications Corporation
Reference29 articles.
1. 1. Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. PMID: 20301425.
2. 2. Starr J, Ramnaraign B. Germline BRCA1 mutated esophageal squamous cell carcinoma. Rare Tumors. 2020 Nov 5;12:2036361320972218. doi: 10.1177/2036361320972218. PMID: 33224455; PMCID: PMC7649882.
3. 3. Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015 Jan 15;121(2):269-75. doi: 10.1002/cncr.29041. Epub 2014 Sep 15. Erratum in: Cancer. 2015 Jul 15;121(14):2474-5. doi: 10.1002/cncr.29357. PMID: 25224030; PMCID: PMC4293332.
4. 4. van Nistelrooij AM, Dinjens WN, Wagner A, Spaander MC, van Lanschot JJ, Wijnhoven BP. Hereditary Factors in Esophageal Adenocarcinoma. Gastrointest Tumors. 2014 Jun;1(2):93-8. doi: 10.1159/000362575. Epub 2014 May 9. PMID: 26675496; PMCID: PMC4645576.
5. 5. Esophageal and Esophagogastric Junction Cancers. NCCN Clinical Practice Guidelines in Oncology. Version 3.2023.